ReviewObesity pillars2026

Micronutrient risk with GLP-1 receptor and dual incretin agonists in obesity: Mechanistic pathways, clinical signals, and a monitoring framework.

Daniel Simancas-Racines et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.